Back to 
BANK OF NOVA SCOTIA
BANK OF NOVA SCOTIA
NKTR
Showing 0 of 2 quarters
Position history for BANK OF NOVA SCOTIA's holdings in NEKTAR THERAPEUTICS
No. Bank of Nova Scotia exited its NKTR (Nektar Therapeutics) position in Q4 2019. Its Q3 2019 13F listed 29,975 shares worth $546,000. Bank of Nova Scotia already held NKTR in its Q3 2019 13F, the earliest on record, and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.